Skip to main content

Table 4 Clinical characteristics and distribution of WHO grade in three different ependymoma groups defined by TNC expression and chromosome 1q25 status

From: Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma

  Gender (m:f ratio) Median age years (range) WHO grade (II/III)
TNC pos/1q25 gain
(group 1)
1:1 4.2
(1.4–17.3)
0/10
TNC pos/no 1q25 gain
(group 2)
1.4:1 2.1
(0.9–11.3)
8/21
TNC neg/no 1q25 gain
(group 3)
4:1 9.9
(3.6–20)
5/0